PMC:7463108 / 106500-106625 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T66339","span":{"begin":20,"end":33},"obj":"Chemical"},{"id":"T71773","span":{"begin":79,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A99991","pred":"chebi_id","subj":"T66339","obj":"http://purl.obolibrary.org/obo/CHEBI_3216"},{"id":"A86945","pred":"chebi_id","subj":"T71773","obj":"http://purl.obolibrary.org/obo/CHEBI_37924"}],"text":"Dose adjustments of buprenorphine are recommended when initiating therapy with atazanavir to avoid symptoms of opioid excess."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3608","span":{"begin":20,"end":33},"obj":"Chemical"},{"id":"3609","span":{"begin":79,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A3608","pred":"tao:has_database_id","subj":"3608","obj":"MESH:D002047"},{"id":"A3609","pred":"tao:has_database_id","subj":"3609","obj":"MESH:D000069446"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Dose adjustments of buprenorphine are recommended when initiating therapy with atazanavir to avoid symptoms of opioid excess."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1337","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Dose adjustments of buprenorphine are recommended when initiating therapy with atazanavir to avoid symptoms of opioid excess."}